Topical minoxidil in early male pattern baldness

Area of Science:

• Dermatology
• Hair Restoration Science

Background:

• Male pattern baldness, also known as androgenetic alopecia, affects a significant portion of the male population.
• Early intervention is crucial for managing hair loss progression.

Purpose of the Study:

• To evaluate the efficacy of topical minoxidil in promoting hair growth in men with early male pattern baldness.
• To compare the effects of 2% and 3% topical minoxidil formulations against a placebo.

Main Methods:

• A 12-month, double-blind, randomized controlled trial involving 126 healthy men with early male pattern baldness.
• Participants were assigned to placebo, 2% topical minoxidil, or 3% topical minoxidil. The placebo group was later switched to 3% topical minoxidil.
• Objective hair counts (vellus, terminal, total) and subjective assessments by participants and investigators were performed.

Main Results:

• Treatment with topical minoxidil led to a statistically significant increase in terminal hair growth compared to placebo.
• Men initially receiving placebo showed significant terminal hair count increases after switching to topical minoxidil.
• No participants experienced a net loss of hair in the targeted balding area during the study period.

Conclusions:

• Topical minoxidil is an effective treatment for increasing terminal hair growth in individuals with early male pattern baldness.
• Both 2% and 3% concentrations demonstrated positive effects, with sustained use showing continued benefits.
• The study supports the use of topical minoxidil as a therapeutic option for managing androgenetic alopecia.